The Impact of Physical Exercise on Sleep in Colorectal Cancer Patients During Prehabilitation Period

April 5, 2022 updated by: Sender Liberman MD, Montreal General Hospital

The Impact of Physical Exercise on Sleep Quality and Duration in Colorectal Cancer Patients During Prehabilitation Period: A Pilot Study

Main objective: To evaluate the bidirectional relationships between physical exercise and sleep parameters, as a part of multimodal prehabilitation intervention, on pre- and postoperative outcomes in surgical patients with colorectal cancer, in an RCT.

Secondary objective: to determine whether the levels of anxiety and depression affect these relationships.

Objectives are based on the overarching hypothesis that is sleep and physical activity influence each other through complex, reciprocal interactions including multiple physiological and psychological pathways. To achieve this, providing a multimodal prehabilitation, specifically physical exercise, involved in mental and physical health through different mechanisms, i.e., improving physical functioning and fitness, reducing side effects of cancer treatments, preventing bone loss and weight gain, improving the quality of life and sleep, decreasing symptoms of fatigue and depression.

The present is a pilot study aiming to evaluate the bidirectional relationships between sleep and physical exercise, and the preliminary outcome has important implications for informing both clinical and public health practice.

Research question: Does a multimodal intervention including physical exercise improve sleep quality and duration compared to standard of care, during the perioperative period? Conversely, does a better sleep quality and duration increases the level of physical exercise during the perioperative period? How the level of anxiety and depression will affect these relationships? If the Prehabilitation program specifically physical exercise will positively affect sleep quality and duration after surgery, in the way to be a protective factor of sleep to not be reduced by up to 55% compared to those receiving standard of care?

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Participants will be referred by colorectal surgery of the MUHC-Montreal General Hospital; 100 participants will be studied. Inclusion: adult patients aged 18 years and older, of either sex undergoing colorectal cancer surgery. All adult persons scheduled for resection of malignant colorectal lesions will be included. Exclusion criteria: a compromised health status (American Society of Anesthesiologists [ASA] class 4-5) or comorbid medical conditions interfering with the ability to perform an exercise. Patients are unable to understand the information given, insufficient understanding of English or French language to provide informed consent or who are considered unable to perform study-specific procedures. Patients that diagnosis of a sleep disorder other than insomnia (e.g., sleep-disordered breathing) or received psychotherapy specifically for insomnia, as well as a night-shift worker in the past 3 months or the next 18 months will be excluded.

Study Design: Randomized controlled trial of two parallel arms: prehabilitation program and standard of care (SOC). Informed consent forms will be signed and dated before the conduct of any study-specific procedures. After baseline assessment, participants will be random, by a computer program, allocated to either an intervention or a control group. Duration and follow-up. The intervention will last for 4 weeks pre- and 8 weeks post-surgery, for a total of 12 weeks. Site visits will occur weekly before surgery and every 4 weeks after surgery. In that period, weekly phone calls will reinforce compliance and provide tips to help patients adhere to the treatment protocol. A dedicated and specially trained research team lead by a physician, a kinesiologist, a nutritionist and a psychologist will perform the measurements and collect the demographic and surgical details of all the patients, recording daily detailed information of clinical outcomes up to 8 weeks after surgery.

Interventions: Common to both groups: as part of the enhanced recovery after surgery (ERAS) protocol as the standard of care in our institution. All participants will wear an actigraphy to objectively assess their daily physical activity and their sleep behavior. The following outcomes will be assessed for all participants, at the baseline and will be repeated after 4 weeks, before and after the surgery: sleep behaviors included sleep quality and duration, assessed subjectively and objectively. Self-reported and objective outcome measurements will be assessed from all participants such as the 6-minute walk distance (6MWD), daily activity counts, exercise tolerance (CPET) and handgrip strength, Insomnia Severity Index (ISI), Chronotype, health-related quality of life assessed by using the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and the Hospital Anxiety and Depression Scale (HADS) used to assess emotional distress.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H3G 1A4
        • Recruiting
        • McGill University Health Centre
        • Contact:
        • Principal Investigator:
          • Sender Liberman, MD
        • Principal Investigator:
          • Franco Carli, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All adult persons scheduled for resection of malignant colorectal lesions will be included

Exclusion Criteria:

  • A compromised health status (American Society of Anesthesiologists [ASA] class 4-5) or comorbid medical conditions interfering with the ability to perform an exercise.
  • Patients are unable to understand the information given, insufficient understanding of English or French language to provide informed consent or who are considered unable to perform study-specific procedures.
  • Patients that diagnosis of a sleep disorder other than insomnia (e.g., sleep-disordered breathing) or received psychotherapy specifically for insomnia, as well as a night-shift worker in the past 3 months or the next 18 months will be excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Prehabilitation program
The preoperative period (prehabilitation) represents a more appropriate time than the postoperative period to implement an intervention. Prehabilitation is a process of enhancing an individual's functional capacity before the scheduled surgery, aimed at improving the patient's tolerance to upcoming physiologic stress, by three principal elements: exercise training, nutritional intervention, and psychological support.
The preoperative period (prehabilitation) represents a more appropriate time than the postoperative period to implement an intervention. Prehabilitation is a process of enhancing an individual's functional capacity before the scheduled surgery, aimed at improving the patient's tolerance to upcoming physiologic stress, by three principal elements: exercise training, nutritional intervention, and psychological support.
No Intervention: Standard of care (SOC)
Common to both groups as part of the enhanced recovery after surgery (ERAS) protocol as the standard of care in our institution.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pittsburgh Sleep Quality Index (PSQI): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
This questionnaire was developed to assess the global subjective sleep disturbances of the previous month. The PSQI is a 19-item self-report measure of broad sleep disturbances over the past month and yields 7 component scores (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, and daytime dysfunction), which are added to create a total score. Each score ranging from 0 to 3 and a total score range of 0-21, a score of 0 indicated no sleep problems and 3 indicated serious sleep problems.
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Sleep quality by an Actigraphy: "change" is being assessed
Time Frame: 4 weeks before surgery and 4 weeks after the surgery
Sleep quality will be objectively measured using the Actiwatch-2. The Actiwatch-2 (Philips, Respironics) is a small, waterproof, non-intrusive actigraphy device that is worn on the wrist of the non-dominant hand. By calculating orientation and movement, actigraphy records sleep-wake activity and provide an objective measure of sleep quality.
4 weeks before surgery and 4 weeks after the surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Community Health Activities Model Program for Seniors (CHAMPS) questionnaire: "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.

The CHAMPS is a self-reported measure of physical activity, comprising 41 activities evaluated according to the total number of hours done during an average week. The CHAMPS has been validated as a measure of increasing levels of physical activity in older adults.

1 METs), low-light (ie, > 1 and ≤2 METs; eg, playing cards), high-light (ie, >2 and <3 METs; eg, light walking), moderate-to-vigorous physical activity (MVPA, ≥3 METs), and "total activity" (≥2 METs)

At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Daily activity counts measured by an Actigraphy: "change" is being assessed
Time Frame: 4 weeks before surgery and 4 weeks after the surgery
The Actiwatch-2 (Philips, Respironics) provide an objective measure of the daily activity counts.
4 weeks before surgery and 4 weeks after the surgery
Functional capacity using the six-minute walk test (6MWT): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
The 6MWT evaluates the ability to maintain a moderate level of physical activity reflecting the activities of daily living. Norms available: The six-minute walk distance in healthy adults has been reported to range from 400m to 700m. A lower score (reflecting less distance covered in 6 minutes) indicates worse function.
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Hospital Anxiety and Depression Scale (HADS): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
The HADS contains seven items, each scored from 0 to 3 points for anxiety and depression. It provides summary measures on a scale of 0-21, with scores exceeding 8 suggesting the presence of a mood disorder.
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insomnia Severity Index (ISI): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.

To report the perceived severity of difficulties falling asleep, difficulties maintaining sleep and early morning awakenings, as well as the degree of dissatisfaction with current sleep, the degree to which sleep difficulties interfere with daytime functioning, the degree to which the deterioration of functioning related to the sleep problem is noticeable by others, and the level of distress or worry caused by the sleep difficulties.

The total score is interpreted as follows: the absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).

At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Chronotype: "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
One hears about 'morning' and 'evening' types of people with 5 response categories.
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Health-related quality of life will be assessed using the Medical Outcomes Study 36-Item: "change" is being assessed Short-Form Health Survey (SF-36)
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
A reliable and valid generic index of perceived health status for cancer patients and used on the previous study for patients undergoing scheduled colorectal surgery. 36-item patient-reported questionnaire that covers eight health domains: physical functioning (10 items), bodily pain (2 items), role limitations due to physical health problems (4 items), role limitations due to personal or emotional problems (4 items), emotional well-being (5 items), social functioning (2 items), energy/fatigue (4 items), and general health perceptions (5 items). Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
The World Health Organization Disability Assessment Schedule (WHODAS 2.0): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.

12 items used to measures disability due to health conditions including diseases, illnesses, injuries, mental or emotional problems, and problems with alcohol or drugs.

The sum score for global disability therefore ranges from 0 (no disability) to 48 (complete disability).

At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Patient-Generated Subjective Global Assessment (PG-SGA): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Validated for oncologic patients, it comprises 4 scored domains: recent weight loss, food intake, symptoms, and activities and functions. PG-SGA Short Form is a patient-reported instrument for the assessment of nutrition status in patients with cancer. The PG-SGA Short Form numerical scoring range from 0 (no problems) to 36 (worst problem).
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
The oxygen peak during cardiopulmonary exercise testing (CPET): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.

CPET has a growing role in major abdominal surgery to guide decision-making by clinicians and to evaluate the consequences of neo-adjuvant therapies and prehabilitation programs.

The term 'peak VO2' is used as a synonym for VO2 max throughout this text. Peak VO2 is considered abnormal when below 85% of the predicted value.

At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Anaerobic threshold (AT) measured during cardiopulmonary exercise testing (CPET): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
The VO2 value measured in the first ventilatory threshold (VT1) or anaerobic threshold (AT) is determined by the nonlinear increase of pulmonary ventilation (VE) in relation to VO2. The normal mean AT values expected for adults is around 40% to 65% of peak VO2.
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Pulmonary ventilation measured during cardiopulmonary exercise testing (CPET): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Pulmonary ventilation (VE): Ventilation increases continuously during progressive effort on CPET and undergoes additional increases influenced by the anaerobic metabolism resulting from the accumulation of lactic acid, well defined as the first and second ventilatory thresholds. Periodic (or oscillatory) ventilation is defined as the resting oscillatory pattern that persists in ≥ 60% of the effort with an amplitude of ≥ 15% as compared to mean resting values.
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
CO2 production: "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
CO2 production measured during cardiopulmonary exercise testing (CPET)
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
O2 consumption: "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
O2 consumption measured during cardiopulmonary exercise testing (CPET)
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Respiratory coefficient measured during cardiopulmonary exercise testing (CPET): "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Respiratory coefficient or respiratory exchange ratio (R): expresses the ratio between CO2 production and O2 consumption (VCO2/VO2). It is currently the best non-invasive indicator of maximal or quasi-maximal exercise intensity. Values above 1.0 can reflect intense exercise, but those ≥ 1.10 are those searched on CPET, and have been accepted as a parameter of exhaustion or quasi-exhaustion.
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Muscle strength Handgrip strength will be measured with the Jamar hydraulicdynamometer, in kg: "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.

Maximal strength will be recorded, according to standardized procedures. Isokinetic leg strength will be measured with a Biodex on the dominant side.

Loss of muscle strength was defined as < 30kg (men) and < 20 kg (women).

At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Height: "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Height with a ruler on the wall measured in cm
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Weight: "change" is being assessed
Time Frame: At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.
Bodyweight will be measured by a digital scale by the Seca mBCA machine in kg
At the baseline, it will be repeated the week of the surgery and at 4 and 8 weeks after the surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sender Liberman, MD, McGill University Health Centre/Research Institute of the McGill University Health Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2020

Primary Completion (Anticipated)

September 30, 2022

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

February 7, 2020

First Submitted That Met QC Criteria

February 12, 2020

First Posted (Actual)

February 17, 2020

Study Record Updates

Last Update Posted (Actual)

April 7, 2022

Last Update Submitted That Met QC Criteria

April 5, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Prehabilitation program

3
Subscribe